{'52WeekChange': -0.8248062,
 'SandP52WeekChange': 0.0644362,
 'address1': 'Harcourt Centre',
 'address2': 'Block 2, Floor 3 Harcourt Street',
 'algorithm': None,
 'annualHoldingsTurnover': None,
 'annualReportExpenseRatio': None,
 'ask': 1.13,
 'askSize': 2200,
 'averageDailyVolume10Day': 769450,
 'averageVolume': 1263561,
 'averageVolume10days': 769450,
 'beta': 1.235064,
 'beta3Year': None,
 'bid': 1.13,
 'bidSize': 1800,
 'bookValue': -2.807,
 'category': None,
 'circulatingSupply': None,
 'city': 'Dublin',
 'companyOfficers': [],
 'country': 'Ireland',
 'currency': 'USD',
 'dateShortInterest': 1593475200,
 'dayHigh': 1.17,
 'dayLow': 1.0923,
 'dividendRate': None,
 'dividendYield': None,
 'earningsQuarterlyGrowth': None,
 'enterpriseToEbitda': -0.372,
 'enterpriseToRevenue': None,
 'enterpriseValue': 35096940,
 'exDividendDate': None,
 'exchange': 'NGM',
 'exchangeTimezoneName': 'America/New_York',
 'exchangeTimezoneShortName': 'EDT',
 'expireDate': None,
 'fiftyDayAverage': 1.3362857,
 'fiftyTwoWeekHigh': 7.65,
 'fiftyTwoWeekLow': 0.92,
 'fiveYearAverageReturn': None,
 'fiveYearAvgDividendYield': None,
 'floatShares': 10404266,
 'forwardEps': -2.05,
 'forwardPE': -0.5512195,
 'fromCurrency': None,
 'fullTimeEmployees': 44,
 'fundFamily': None,
 'fundInceptionDate': None,
 'gmtOffSetMilliseconds': '-14400000',
 'heldPercentInsiders': 0.03577,
 'heldPercentInstitutions': 0.70066,
 'industry': 'Biotechnology',
 'isEsgPopulated': False,
 'lastCapGain': None,
 'lastDividendValue': None,
 'lastFiscalYearEnd': 1577750400,
 'lastMarket': None,
 'lastSplitDate': None,
 'lastSplitFactor': None,
 'legalType': None,
 'logo_url': 'https://logo.clearbit.com/iterumtx.com',
 'longBusinessSummary': 'Iterum Therapeutics plc, a clinical-stage '
                        'pharmaceutical company, engages in developing '
                        'anti-infectives for multi-drug resistant pathogens in '
                        'Ireland and the United States. The company is '
                        'developing sulopenem, a novel penem anti-infective '
                        'compound with oral and IV formulations that is in '
                        'Phase III clinical trials for the treatment of '
                        'uncomplicated urinary tract infections, complicated '
                        'urinary tract infections, and complicated '
                        'intra-abdominal infections. Iterum Therapeutics plc '
                        'was founded in 2015 and is headquartered in Dublin, '
                        'Ireland.',
 'longName': 'Iterum Therapeutics plc',
 'market': 'us_market',
 'marketCap': 20159990,
 'maxAge': 1,
 'maxSupply': None,
 'messageBoardId': 'finmb_318354064',
 'morningStarOverallRating': None,
 'morningStarRiskRating': None,
 'mostRecentQuarter': 1585612800,
 'navPrice': None,
 'netIncomeToCommon': -98650000,
 'nextFiscalYearEnd': 1640908800,
 'open': 1.17,
 'openInterest': None,
 'payoutRatio': 0,
 'pegRatio': None,
 'phone': '353 1 903 8920',
 'previousClose': 1.145,
 'priceHint': 4,
 'priceToBook': None,
 'priceToSalesTrailing12Months': 'Infinity',
 'profitMargins': 0,
 'quoteType': 'EQUITY',
 'regularMarketDayHigh': 1.17,
 'regularMarketDayLow': 1.0923,
 'regularMarketOpen': 1.17,
 'regularMarketPreviousClose': 1.145,
 'regularMarketPrice': 1.17,
 'regularMarketVolume': 331453,
 'revenueQuarterlyGrowth': None,
 'sector': 'Healthcare',
 'sharesOutstanding': 17840700,
 'sharesPercentSharesOut': 0.0215,
 'sharesShort': 384689,
 'sharesShortPreviousMonthDate': 1590710400,
 'sharesShortPriorMonth': 448570,
 'shortName': 'Iterum Therapeutics plc',
 'shortPercentOfFloat': 0.043,
 'shortRatio': 0.16,
 'startDate': None,
 'strikePrice': None,
 'symbol': 'ITRM',
 'threeYearAverageReturn': None,
 'toCurrency': None,
 'totalAssets': None,
 'tradeable': False,
 'trailingAnnualDividendRate': None,
 'trailingAnnualDividendYield': None,
 'trailingEps': -6.728,
 'twoHundredDayAverage': 2.4934676,
 'volume': 331453,
 'volume24Hr': None,
 'volumeAllCurrencies': None,
 'website': 'http://www.iterumtx.com',
 'yield': None,
 'ytdReturn': None,
 'zip': '2'}